ABTC-1802

Study Title: 
A Phase II Study of Binimetinib in Combination with Encorafenib in Adults with Recurrent BRAF V600-Mutated High-Grade Astrocytoma or other Primary Brain Tumor
Lead Group: 
Status: 
Review Status: